Minimally invasive esophagectomy for the treatment of esophageal cancer:a report of 81 cases
10.3760/cma.j.issn.1001-4497.2011.04.012
- VernacularTitle:胸腹腔镜联合手术治疗食管癌81例
- Author:
Baofu CHEN
;
Chengchu ZHU
;
Dehua MA
;
Chunguo WANG
;
Chunlei WU
;
Jiang LIN
;
Bo ZHANG
;
Min KONG
;
Jiahong YE
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasms;
Esophagectomy;
Thoracoscopy;
Laparoscopy
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2011;27(4):218-220
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo assess the feasibility and clinical efficacy of minimally invasive esophagectomy for esophageal cancer.MethodsFrom July 2007 to December 2009,eighty-one patients with esophageal cancer received combined thoracoscopic and laparoscopic esophagectomy with anastomosis in the neck.All clinical data were retrospectively reviewed.ResultsThe median operative time was 270.5 min (range 196-315 min).The median time of gastric mobilization and abdominal lymph node dissection was 64.5 min,and the median time of esophageal dissection and mediastinall lymph node dissection was 81.2 min.The median blood loss was 121.5 ml for the thoracic phase and 42.4 ml for abdomen phase.The mean number of disected lymph nodes was 20.4 (range 5-41) with metastastic rate of 30.9% (25/81).The mean harvest lymph node was 12.5 in chest and 7.3 in abdomen.Perioperative complications rate was 27.2%,including respiratory failure in 1 case,pulmonary infection in 10,anastomotic leak in 3,chylothorax in 2,gastric tube dilatation in 1,gastric tube leak in 1.And recurrent laryneal nerve injury in 5 .Seventy-nine patients were followed up withmMean follow up time of 14.2 months( range 2-31 months).The overall one-year survival rate was 91.1%.Postoperative complications included anastomotic stenosis in 5 cases (6.3%),reflux esophagitis in 12 (15.2%) and recurrence or metastasis in 6 (7.6%).ConclusionMinimally invasive esophagectomy for esophageal cancer can mimimus trauma,reduce post-operative complications,improve the quality of life,which is feasible and effective from the point of the clinical efficacy and the purpose of tumor therapy.
